Atlas Trials

Sutent Maintenance After Response to Taxotere

Clinical trial NCT00550810 · UNKNOWN

Trial details

NCT number
NCT00550810
Sponsor
Alberta Health services
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate CancerHormone Refractory
Start date
2007-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.